Skip to content

Clinical trials

Completed Phase 2 Respiratory Tract Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Tract Diseases Phase: Phase 2 Status: Completed Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20031
20071
20082
20093
20102
20111
20121
20132
20142
20151
20163
20171
20181
20192
20202
20211
20222
20234
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed42

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Medicago6
AstraZeneca4
National Center for Research Resources (NCRR)4
Upstream Bio Inc.2
Altair Therapeutics, Inc.1
Altesa Biosciences, Inc.1
Assistance Publique - Hôpitaux de Paris1
Bayer1
Biomedical Advanced Research and Development Authority1
Cardeas Pharma1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Tract Diseases42
Lung Diseases19
Respiratory Tract Infections16
Virus Diseases12
RNA Virus Infections11
Infections9
Asthma8
Influenza, Human8
Orthomyxoviridae Infections8
Rare Diseases7

Trials

Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.